Augusta A Mikhailova

Title: Augusta A Mikhailova: Innovator in Therapeutic Peptides

Introduction

Augusta A Mikhailova is a notable inventor based in Moscow, Russia. She has made significant contributions to the field of biochemistry, particularly in the development of therapeutic peptides. Her work focuses on the creation of peptides that possess immunostimulating and anti-viral properties.

Latest Patents

Mikhailova holds a patent for her invention titled "Myelopeptides and their therapeutic use." This patent encompasses peptides comprising 4 to 10 amino acids, including specific sequences such as X-Pro, Pro-X, or X-Pro-X. The amino acids in these peptides are selected from a range of options, including Lys, Arg, His, Asp, Glu, Asn, and Gln. Notable peptides from her research include LVCYPQ (SEQ ID NO: 3), FRPRIMTP (SEQ ID NO: 4), VVYPD (SEQ ID NO: 5), and VDPP (SEQ ID NO: 6). These peptides are derived from porcine bone marrow cell culture and exhibit promising therapeutic properties.

Career Highlights

Mikhailova's career is marked by her innovative research and dedication to advancing medical science. She has successfully developed a unique approach to peptide synthesis that has the potential to impact therapeutic applications significantly. Her work has garnered attention in the scientific community, highlighting her as a leading figure in her field.

Collaborations

Mikhailova collaborates with esteemed colleagues, including Larissa A Fonina and Rem V Petrov. These partnerships enhance her research efforts and contribute to the advancement of therapeutic peptide development.

Conclusion

Augusta A Mikhailova's contributions to the field of therapeutic peptides are noteworthy and impactful. Her innovative work continues to pave the way for advancements in medical treatments.